Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 3, 2006, Pages 277-284

  Voltersvik, Pål ^a,b   Bostad, Leif ^b   Dyrhol Riise, Anne Margarita ^a,c   Eide, Geir Egil ^a,c   Røsok, Bård Ingvald ^a,d   Olofsson, ^c   Åsjö, Birgitta ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cystatin A; Follicular lymphoid tissue; Highly active antiretroviral therapy; Viral load

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CYSTEINE PROTEINASE INHIBITOR; INDINAVIR; LAMIVUDINE; STEFIN A; VIRUS RNA; ZIDOVUDINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FOLLICULAR DENDRITIC CELL; GERMINAL CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPH FOLLICLE; LYMPHOID TISSUE; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TONSIL CELL; VIRUS PATHOGENESIS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CYSTATINS; FEMALE; GERMINAL CENTER; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MALE; MIDDLE AGED; RNA, VIRAL; TONSIL; VIRAL LOAD;

EID: 33645101932     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000199234.77081.a2     Document Type: Article

References (41)

1. Jarvinen M, Hopsu-Havu VK. Alpha-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B?) from rat skin. I. Preliminary experiments from skin extract. Acta Chem Scand B. 1975;29:243-247.
2. Rinne A, Jarvinen M, Rasanen O. A protein reminiscent of epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat. Acta Histochem. 1978;63:183-192.
3. Rinne A, Alavaikko M, Jarvinen M, et al. Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymphoid node germinal centres. Virchows Arch B Cell Pathol. 1983;43:121-126.
4. Soderstrom KO, Rinne R, Hopsu-Havu VK, et al. Identification of acid cysteine proteinase inhibitor (cystatin A) in the human thymus. Anat Rec. 1994;240:115-119.
5. Green GD, Kembhavi AA, Davies ME, et al. Cystatin-like cysteine proteinase inhibitors from human liver. Biochem J. 1984;218:939-946.
6. Davies ME, Barratt AJ. Immunolocalisation of human cystatins in neutrophils and lymphocytes. Histochemistry. 1984;80:373-377.
7. Soderstrom KO, Laato M, Wu P, et al. Expression of acid cysteine proteinase inhibitor (APCI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma. Int J Cancer. 1995;62:1-4.
8. Barrett AJ. The cysteines: a new class of peptidase inhibitors. Trends Biochem Sci. 1987;236:193-196.
9. Eide TJ, Jarvinen M, Hopsu-Havu VK, et al. Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix. Acta Histochem. 1992;93:241-248.
10. Bjørklund HV, Johanson TR, Rinne A. Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. J Virol. 1997;71:5658-5662.
11. van Eijk M, de Groot C. Germinal-center B-cell apoptosis requires both caspase and cathepsin activity. J Immunol. 1999;163:2478-2482.
12. van Eijk M, Defrance T, Hennino A, et al. Death-receptor contribution to the germinal-center reaction. Trends Immunol. 2001;22:677-682.
13. Shugras DC. Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis. 1999;179(Suppl 3):S431-S435.
14. Challacombe SJ, Sweet SP. Oral mucosal immunity and HIV infection: current status. Oral Dis. 2002;8(Suppl 2):55-62.
15. Guy B, Geist M, Dott K, et al. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol. 1991;65:1325-1331.
16. Alavaikko M, Rinne A, Jarvinen M, et al. Damage to secondary lymphoid follicles in AIDS-related persistent generalized lymphadenopathy, as revealed by behaviour of dendritic reticulum cells possessing immunoreactive acid cysteine-proteinase inhibitor. Virchows Arch. 1986;50:299-311.
17. Biberfeld P, Ost A, Porwit A, et al. Histopathology and immunochemistry of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Scand [A]. 1987;95:47-65.
18. Voltersvik P, Dyrhol-Riise AM, Bostad L, et al. Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. APMIS. 2000;108:539-550.
19. Rosok BI, Bostad L, Voltersvik P, et al. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. 1996;10(Suppl):F35-F38.
20. Dyrhol-Riise AM, Voltersvik P, Olofsson J. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS. 1999;13:2365-2376.
21. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
22. Kuopio T, Kankaanranta A, Jalava P, et al. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res. 1998;58:432-436.
23. Rinne A, Dorn A, Jarvinen M, et al. Immunoelectron microscopical location of the acid cysteine proteinase inhibitor in the lymphatic tissue of the tonsils. Acta Histochem. 1986;79:137-145.
24. Baak JPA, ed. Manual of Quantitative Pathology in Cancer Diagnosis. 1st ed. Berlin: Springer-Verlag; 1991.
25. Parmentier HK, van Wichen D, Sie-Go DM, et al. HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells. Am J Pathol. 1990;137:247-251.
26. Dyrhol-Riise AM, Voltersvik P, Berg O, et al. Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterisation. AIDS Res Hum Retroviruses. 2001;17:577-586.
27. Norman GR, Streiner DL, eds. Biostatistics. The Bare Essentials. 2nd ed. London: BC Decker; 2000.
28. SPSS. Base 11.0 User's Guide [computer program]. Chicago: SPSS; 2001.
29. Orenstein JM, Feinberg M, Yoder C, et al. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in AIDS patients. AIDS. 1999;13:2219-2229.
30. Saag MS. Initiation of antiretroviral therapy: implications of recent findings. Presented at: International AIDS Society-USA Course; 2004; New York.
31. Zhang ZQ, Schuler T, Cavert W, et al. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci USA. 1999;96:5169-5172.
32. Schacker TW, Nguyen PL, Martinez E, et al. Persistent abnormalities in lymphoid tissue of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. J Infect Dis. 2002;186:1092-1097.
33. Alos L, Navarrete P, Morente V, et al. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod Pathol. 2005;18:127-136.
34. Racz P. Molecular, biologic, immunohistochemical, and ultrastructural aspects of lymphoid spread of the human immunodeficiency virus type. Lymphology. 1988;21:28-35.
35. Fox CH, Tenner-Racz K, Racz P, et al. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis. 1991;164:1051-1057.
36. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinical latent stage of disease. Nature. 1993;362:355-358.
37. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 1996;274:985-989.
38. Hufert FT, van Lunzen J, Jannosy G, et al. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS. 1997;11:849-857.
39. Stellbrink HJ, van Lunzen J. Lymph nodes during antiretroviral therapy. Curr Opin Infect Dis. 2001;14:17-22.
40. Burton GF, Keele BF, Estes JD, et al. Follicular dendritic cell contributions to HIV pathogenesis. Immunology. 2002;14:275-284.
41. Dyrhol-Riise AM, Ohlsson M, Skarstein K, et al. T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy. Clin Immunol. 2001;101:180-191.